US-based Bristol-Myers Squibb has agreed to acquire F-Star Alpha, a Vienna-based company backed by Atlas Venture, Aescap Venture and TVM Capital among others, for up to $475m.
GP had previously made an offer of SEK 70 per share, which was later increased to SEK 72 per share
Company intends to boost its production capability, bolster its international expansion and pursue a buy-and-build strategy
Accommodation booking site raised €21m from HV Holtzbrinck, Lakestar and Picus Capital in February
British Patient Capital commits $35m, while the European Investment Fund also contributes